Bringing a drug to the US market requires a structured regulatory pathway. From preclinical research and IND submission to clinical trials, NDA or BLA filing, and FDA review, each stage evaluates safety, efficacy, and quality. A clear regulatory strategy helps streamline submissions, address compliance requirements, and move medicines closer to patient access.
